A pilot clinical study of VAL-413 (oral irinotecan HCl) in patients with recurrent pediatric solid tumors.Dennis Brown,Jeffrey A. Bacha,James I. Geller,Patrick A. Thompson,Javier E. Oesterheld,Sarath Kanekal,Markos Leggas,Lorena Lopez,Neil Sankar, Noymi Yam,Lars M. WagnerJOURNAL OF CLINICAL ONCOLOGY(2022)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要